In a report released yesterday, Ben Hendrix from RBC Capital reiterated a Buy rating on Elevance Health (ELV – Research Report), with a price ...
Financial writer discusses RBC Capital's bullish outlook on Carvana, citing upside potential in retail unit estimates and path to durable free cash flow.
Investing.com -- RBC Capital Markets on Monday upgraded Carvana (NYSE:CVNA) shares to Outperform, and lifted the target price to $280 from $270. According to the firm’s analysts, following ...
Each year, RBC supports thousands of students from different educational backgrounds in exploring various career paths within ...
Investors in fertilizer equities can expect steady prices and good cash generation, according to analysts at RBC Capital Markets.
A small change in BBVA’s takeover offer for Banco Sabadell SA announced Thursday seems to be a correction of a previous ...
周二,RBC Capital Markets调整了对Intra-Cellular Therapies股票的立场,将这家生物制药公司的评级从"跑赢大市"下调至"与大市同步"。然而,该公司将股票目标价从之前的108美元上调至132美元。这一调整是在上周强生公司 (JNJ)宣布计划以约146亿美元收购Intra-Cellular Therapies之后做出的。
Meta CEO Mark Zuckerberg announced this morning that the company intends to spend $60B-$65B in capital expenditures for the year, which RBC ...